Back to funds

Kynam Capital Management, LP

Updated 6 days ago

Managed by Kynam Capital Management, Lp • Latest filing Q3 2026

Portfolio value
$1.8B
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$1.6B
Q1 2026$1.6B
Q2 2026$1.8B
Q3 2026$1.8B

Top holdings

34 positions as of Q3 2026

View filing
L

LEGEND BIOTECH CORP

Value
$182.1M
Shares
9.15M
% Port
10.08%
C

CELLDEX THERAPEUTICS INC NEW

Value
$164.2M
Shares
5.07M
% Port
9.09%
S

SYNDAX PHARMACEUTICALS INC

Value
$153.2M
Shares
8.15M
% Port
8.48%
P

VAXCYTE INC

Value
$148.4M
Shares
2.61M
% Port
8.22%
V

VIRIDIAN THERAPEUTICS INC

Value
$126.6M
Shares
6.15M
% Port
7.01%
C

COGENT BIOSCIENCES INC

Value
$121.4M
Shares
3.79M
% Port
6.72%
T

TRAVERE THERAPEUTICS INC

Value
$117.8M
Shares
2.00M
% Port
6.52%
U

UROGEN PHARMA LTD

Value
$98.9M
Shares
2.43M
% Port
5.48%
V

VERA THERAPEUTICS INC

Value
$96.9M
Shares
3.00M
% Port
5.36%
B

BEAM THERAPEUTICS INC

Value
$96.2M
Shares
3.93M
% Port
5.33%
C

CYTOMX THERAPEUTICS INC.

Value
$57.5M
Shares
21.14M
% Port
3.18%
M

MBX BIOSCIENCES INC

Value
$54.8M
Shares
934.8K
% Port
3.03%
S

SUMMIT THERAPEUTICS INC

Value
$50.7M
Shares
3.00M
% Port
2.81%
R

RELAY THERAPEUTICS INC

Value
$49.7M
Shares
2.75M
% Port
2.75%
C

CULLINAN THERAPEUTICS INC

Value
$47.8M
Shares
3.11M
% Port
2.65%
I

IMMUNOCORE HLDGS PLC

Value
$41.6M
Shares
1.38M
% Port
2.31%
N

NURIX THERAPEUTICS INC

Value
$28.3M
Shares
1.19M
% Port
1.57%
P

PHARVARIS N V

Value
$26.2M
Shares
824.8K
% Port
1.45%
B

BURNING ROCK BIOTECH LTD

Value
$21.8M
Shares
1.24M
% Port
1.21%
B

BIOCRYST PHARMACEUTICALS INC

Value
$21M
Shares
2.52M
% Port
1.16%

Explore